Diasorin SpA logo

Diasorin SpA

€ 121.35 (+1.34%) Feb 3
On watch
P/E:
23.16
P/B:
4.01
Market Cap:
€ 6.53B ($ 7.07B)
Enterprise V:
€ 7.52B ($ 8.15B)
Volume:
124.28K
Avg Vol (2M):
125.15K
Also Trade In:
Volume:
124.28K
Market Cap €:
6.53B
Market Cap $:
7.07B
PE Ratio:
23.16
Avg Vol (2-Month):
125.15K
Enterprise Value €:
7.52B
Enterprise Value $:
8.15B
PB Ratio:
4.01

Business Description

Description
DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics--testing done on samples taken from the human body, such as blood and issue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (55% of sales) and molecular diagnostics (35%) and has a total installed base of over 9,000 diagnostic systems. Licensed technologies contribute the remaining 10% of total sales, DiaSorin has a strong presence in Europe, the Middle East, and Africa; the region accounts for the largest portion of company revenue (44%), followed by North America (41%), Asia-Pacific (11%), and Latin America (4%).